You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR PANZYGA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for PANZYGA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02638207 ↗ Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy Completed Octapharma Phase 3 2017-09-27 Study to evaluate the Efficacy and Safety of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly(radiculo)neuropathy
NCT03166527 ↗ Panzyga in CIDP Administered at Different Infusion Rates Unknown status Vera Bril Phase 3 2017-06-01 Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable form of peripheral neuropathy with suspected autoimmune cause. The current first-line treatment is IVIG (immune globulin), which is infused in a set regimen that requires 4-5 hours in a hospital day unit, taking up resources such as nursing time and hospital space. Chronic treatment is required in most cases.
NCT04929236 ↗ Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients Not yet recruiting Octapharma Phase 3 2021-12-01 Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for PANZYGA

Condition Name

Condition Name for PANZYGA
Intervention Trials
Chronic Inflammatory Demyelinating Poly(Radiculo)Neuropathy 1
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 1
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for PANZYGA
Intervention Trials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 2
Polyneuropathies 2
Peripheral Nervous System Diseases 1
Polyradiculoneuropathy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for PANZYGA

Trials by Country

Trials by Country for PANZYGA
Location Trials
Canada 3
Hungary 1
Russian Federation 1
Bulgaria 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for PANZYGA

Clinical Trial Phase

Clinical Trial Phase for PANZYGA
Clinical Trial Phase Trials
Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for PANZYGA
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PANZYGA

Sponsor Name

Sponsor Name for PANZYGA
Sponsor Trials
Octapharma 2
Vera Bril 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for PANZYGA
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.